Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness

Hypertension

Volumn 57, Issue 6, 2011, Pages 1122-1128

  Kampus, Priit ^a,b,c   Serg, Martin ^a,b   Kals, Jaak ^b,c   Zagura, Maksim ^a,b   Muda, Piibe ^a,c   Karu, Külliki ^c   Zilmer, Mihkel ^b   Eha, Jaan ^a,c  

^a UNIVERSITY OF TARTU   (Estonia)

^b Faculty of Medicine   (Estonia)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

blockers; antihypertensive therapy; central blood pressure; left ventricular mass; pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METOPROLOL; NEBIVOLOL; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; AORTA PRESSURE; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRACHIAL ARTERY; CAROTID FEMORAL PULSE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHOCARDIOGRAPHY; ERYTHROCYTE COUNT; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE WALL; HEART RATE; HEART VENTRICLE WALL; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SMOKING; THROMBOCYTE; TREATMENT DURATION; VASODILATATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; AORTA; BENZOPYRANS; BLOOD PRESSURE; CAROTID ARTERIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; ETHANOLAMINES; FEMALE; FEMORAL ARTERY; HEART RATE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIUM; PULSE; TREATMENT OUTCOME;

EID: 79956343749     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.155507     Document Type: Article

References (27)

1. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 5th ed. London, United Kingdom: Arnold; 2005.
2. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, Umans JG, Calhoun D, Howard BV. High central pulse pressure is independently associated with adverse cardiovascular outcome the Strong Heart Study. J Am Coll Cardiol. 2009;54:1730-1734.
3. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735-738. (Pubitemid 34252866)
4. Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Perez G, Mendez. Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol. 2005;96:645-648. (Pubitemid 41207305)
5. Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR Study. Hypertension. 2010; 55:1314-1322.
6. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation. 2006;113:1213-1225.
7. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:1665-1683.
8. Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens. 2008;26:351-356.
9. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605. (Pubitemid 44627304)
10. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932-937. (Pubitemid 34258696)
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiog. 2005;18:1440-1463.
12. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251-1260.
13. Mahmud A, Feely J.-Blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens. 2008;21:663-667. (Pubitemid 351733365)
14. Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, Van Nueten L, Wooding SJ, Ritter JM. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther. 1995;274:1067-1071.
15. Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. J Hypertens. 2002;20:1793-1797.
16. Burns J, Mary DA, Mackintosh AF, Ball SG, Greenwood JP. Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive. Hypertension. 2004;44:454-458. (Pubitemid 39281495)
17. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17: 1192-1200. (Pubitemid 40029420)
18. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10-15. (Pubitemid 34098081)
19. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure: part II-evidence for specific class-effects ofantihypertensive drugs on pressure amplification. Curr Pharm Des. 2009; 15:272-289.
20. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197-203. (Pubitemid 46986041)
21. Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. J Hypertens. 2010;28: 384-388.
22. Devereux RB, Dahlöf B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial. Circulation. 2004;110:1456-1462. (Pubitemid 39238023)
23. Liu GS, Wang LY, Nueten LV, Ooms LA, Borgers M, Janssen PA. The effect of nebivolol on left ventricular hypertrophy in hypertension. Cardiovasc Drugs Ther. 1999;13:549-551. (Pubitemid 30032264)
24. Fountoulaki K, Dimopoulos V, Giannakoulis J, Zintzaras E, Triposkiadis F. Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan. Am J Hypertens. 2005;18:171-177. (Pubitemid 40332545)
25. Fagard RH, Celis H, Thijs L, Wouters S. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension. 2009;54:1084-1091.
26. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007;369:201-207. (Pubitemid 46111014)
27. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, Kario K. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009;54: 716-723.